NCT02677246 Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children Status WITHDRAWN Phase PHASE1
NCT02632916 Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study Status COMPLETED Phase PHASE2
NCT02559648 Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Status COMPLETED Phase PHASE2
NCT02520362 Denosumab Safety Assessment in Multiple Observational Databases Status COMPLETED Phase N/A
NCT02499237 Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation Status COMPLETED Phase PHASE4
NCT02470091 Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma Status COMPLETED Phase PHASE2
NCT02435147 Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index Status COMPLETED Phase N/A
NCT02418273 Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders Status WITHDRAWN Phase PHASE1/PHASE2
NCT02366130 Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02352753 Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI Status TERMINATED Phase PHASE3
NCT02132026 Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. Status COMPLETED Phase PHASE2
NCT02129699 Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy Status TERMINATED Phase PHASE3